Concepedia

Sharon MacLachlan

SM

12

Publications

570

Citations

11

H-Index

2004

Active since

Affiliations

AstraZeneca (United States)(Current)

EVRAZ (United Kingdom)

University of Basel

Takeda (United Kingdom)

Bristol-Myers Squibb (United Kingdom)

Sharon MacLachlan is an author at AstraZeneca (United States) specializing in orthopaedics, pharmacotherapy, and breast cancer.

Top concepts

Publications per year

2004–2022

12

Publications

12

Prodromal symptoms of multiple sclerosis in primary care

Giulio Disanto, Chiara Zecca, Sharon MacLachlan et al. · Annals of Neurology · 2018 · 159 citations

Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial

Debu Tripathy, M. Lichinitzer, A. F Lazarev et al. · Annals of Oncology · 2004 · 100 citations

, , +9

Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus

David Z.I. Cherney, Enrico Repetto, David C. Wheeler et al. · American Journal of Nephrology · 2019 · 55 citations

Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013

Mireia Raluy-Callado, Dimitra Lambrelli, Sharon MacLachlan et al. · International Journal of COPD · 2015 · 43 citations · Full text

Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma

Trung N. Tran, Sharon MacLachlan, Wesley L. Hicks et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 42 citations

Rows per page

1–5 of 12